HIGHFDA DRUG
Lupin Pharmaceuticals Recalls Sertraline Hydrochloride Tablets for Defective Seal
Lupin Pharmaceuticals recalled 52,128 bottles of Sertraline Hydrochloride Tablets on November 5, 2025. Consumers reported issues with defective seals that do not adhere to the bottles. The recall follows a Class II classification due to potential contamination risks.
SERTRALINE HYDROCHLORIDE
Defective container